An injection for a blood clotting disorder, a rival Botox treatment & more: 4 recent FDA approvals

Four drugs or medical devices approved by the FDA since Feb. 1:

Advertisement

1. Cablivi injection is the first therapy for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura, a rare blood-clotting disorder.

2. Jeuveau is a new wrinkle treatment for adult patients expected to rival Allergan’s Botox.

3. A generic version of the Advair Diskus inhaler, fluticasone propionate and salmeterol inhalation powder, was approved for patients with asthma or chronic obstructive pulmonary disease.

4. The FDA approved Orthofix Medical’s M6-C artificial cervical disk for patients suffering from cervical disc degeneration.

More articles on supply chain:
10 largest medical device companies
How advanced data analytics can optimize procedural supply spend
Supply chain savings tip of the week: Optimize custom procedural trays

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.